Farallon Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-300,000
| Closed | -$13.5M | – | 317 |
|
2021
Q1 | $13.5M | Hold |
300,000
| – | – | 0.07% | 120 |
|
2020
Q4 | $17.1M | Sell |
300,000
-30,000
| -9% | -$1.71M | 0.1% | 92 |
|
2020
Q3 | $16.9M | Sell |
330,000
-385,000
| -54% | -$19.8M | 0.12% | 87 |
|
2020
Q2 | $42.7M | Sell |
715,000
-285,000
| -29% | -$17M | 0.34% | 61 |
|
2020
Q1 | $41.2M | Buy |
1,000,000
+50,000
| +5% | +$2.06M | 0.35% | 48 |
|
2019
Q4 | $59.1M | Buy |
950,000
+200,000
| +27% | +$12.4M | 0.4% | 48 |
|
2019
Q3 | $25.5M | Buy |
+750,000
| New | +$25.5M | 0.19% | 61 |
|
2017
Q4 | – | Sell |
-100,000
| Closed | -$1.9M | – | 91 |
|
2017
Q3 | $1.9M | Buy |
+100,000
| New | +$1.9M | 0.02% | 82 |
|